Célia Reynders
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
-
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
Papers in
- Surgery 4
- Pancreatic function and diabetes 3
-
- Cervical Cancer and HPV Research 2
- Autophagy in Disease and Therapy 1
- Hepatitis B Virus Studies 1
- Co-authors
- Michaël Herfs (5 shared papers)Marie Ancion (4 shared papers)Philippe Delvenne (1 shared paper)Olivier Peulen (3 shared papers)Diane Bruyère (3 shared papers)Stéphanie Demoulin (1 shared paper)Pascale Hubert (3 shared papers)Charlotte Pilard (3 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)eLife (2 papers)Biology (1 paper)Theranostics (1 paper)Journal of Medical Virology (1 paper)
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
Célia Reynders
5 papers receiving 168 citations
Peers
Comparison fields: 5 of 47
- Clinical Biochemistry 37
- Immunology 57
- Cancer Research 23
- Oncology 40
- Neurology 7
Countries citing papers authored by Célia Reynders
This map shows the geographic impact of Célia Reynders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Célia Reynders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Célia Reynders more than expected).
Fields of papers citing papers by Célia Reynders
This network shows the impact of papers produced by Célia Reynders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Célia Reynders. The network helps show where Célia Reynders may publish in the future.
Co-authors
The 25 scholars most cited alongside Célia Reynders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 136 | |
| 2 | 2023 | 16 | |
| 3 | 2023 | 7 | |
| 4 | 2021 | 7 | |
| 5 | 2025 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 0 |
About Célia Reynders
Célia Reynders is a scholar working on Surgery, Epidemiology, Genetics, Molecular Biology and Clinical Biochemistry, having authored 7 papers that have together received 169 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (3 papers), Genetics and Neurodevelopmental Disorders (2 papers), Cervical Cancer and HPV Research (2 papers), Endometrial and Cervical Cancer Treatments (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper), Advanced Glycation End Products research (1 paper), Autophagy in Disease and Therapy (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Clinical Biochemistry (37 citations), Immunology (57 citations), Cancer Research (23 citations), Oncology (40 citations) and Neurology (7 citations). Célia Reynders has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Michaël Herfs, Marie Ancion, Philippe Delvenne, Olivier Peulen, Diane Bruyère, Stéphanie Demoulin, Pascale Hubert, Charlotte Pilard, Elodie Hendrick and Marie‐Julie Nokin. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, eLife, Biology, Theranostics and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.